Introduction {#sec1}
============

Inflammation response plays a crucial role in eliminating pathogens and resisting pathogen invasion \[[@B1]\]. The excessive inflammatory response may lead to inflammatory lesions. Increasing evidence suggests that inflammatory response is related to many diseases and cancer \[[@B2]\]. The complex process of inflammatory response is initiated by innate immune system receptors, which recognize a lot of pathogens or damage signals and precisely regulate immune response. Cells expressing pathogen-recognition receptors (PRRs) are able to present pathogens, antigens and secrete cytokines and chemokines \[[@B3],[@B4]\]. PRRs, such as toll-like receptors (TLRs), activate cellular signalling pathways that result in NF-κB translocating into nucleus, and lead to the production of inflammatory cytokines and chemokines, which directly contribute to inflammatory lesions and immune diseases \[[@B5]\].

NF-κB is an important transcription factor that regulates the transcription and expression of multiple genes. It is closely related to the cell activation, cell proliferation, immune response and inflammatory reaction process \[[@B6]\]. NF-κB comprises a family of proteins such as RelA (p65), RelB, c-Rel, NF-κB1 (p105/p50) and NF-κB2 (p100/p52). The protein p50, the transcript of NF-κB1, is an important subunit of NF-κB. It regulates gene transcription through combination with p65, which is another important subunit of NF-κB. When the signalling pathway is activated, p50/p65 exposes nuclear localization signal and translocates into the nucleus, regulating the transcription of downstream genes. Therefore, p50 protein levels are critical for activation of NF-κB signalling pathway and body's inflammatory reaction \[[@B5]\].

miRNAs are naturally occurring non-coding small RNA molecules capable of degrading the target mRNA or repressing its translation by targeting mRNA 3′-UTR region \[[@B7],[@B8]\]. Overwhelming evidence shows that miRNA-mediated post-transcriptional regulation plays a critical role in inflammatory response and immune regulation \[[@B9],[@B10]\]. *miR-146* is probably one of the most studied miRNA that regulates inflammatory response by targeting TRAF6 and IRAK1 following lipopolysaccharide (LPS)-stimulation \[[@B11]\]. *miR-125b* can target TNF-α resulting in inhibition of inflammatory response \[[@B12]\]. *miR-181a* and *miR-155* regulate inflammation responses by targeting IL-1α respecting TAB2 and SOCS1 \[[@B13],[@B14]\]. However, it remains largely unknown as to how inflammation is regulated by miRNA in immune response.

*miR-322* is the homologue of human *miR-424*, which is differentially expressed in a variety of disease conditions and is highly conserved in different cells \[[@B15]\]. *miR-322/424* is a member of *miR-15/107* family, also known as *miR-16* family \[[@B16],[@B17]\]. It is involved in the regulation of cell proliferation, cell differentiation, diabetes and male infertility \[[@B15],[@B18]--[@B20]\]. In our preliminary study, *miR-322* was predicted to target several sites of inflammatory factors using the software programs. Little is known about the involvement of *miR-322* during inflammatory response. RAW264.7 was a mouse peritoneal macrophage cell line established from a tumour induced by Abelson murine leukaemia virus. It is one of the commonly used inflammatory cell models. Here, we found that the level of *miR-322* was down-regulated in RAW264.7 cells by administration of LPS. We also showed that *miR-322* mimic transfection resulted in an inhibition in pro-inflammatory cytokines mRNA expression, such as IL-1β, IL-6, TNF-α and increased anti-inflammatory cytokines IL-4 and IL-10 expression. Besides, NF-κB1 (p50) was identified as a functional target, through which *miR-322* acted as a negative regulator in macrophage inflammatory response. Moreover, *miR-322* may promote cell-cycle procession and cell proliferation. Our findings demonstrate that the level of *miR-322* is down-regulated by LPS-stimulation and *miR-322* is a negative regulator of the immune response.

Materials and methods {#sec2}
=====================

RAW264.7 cells' culture and treatment {#sec2-1}
-------------------------------------

RAW264.7 was a mouse peritoneal macrophage cell line established from a tumour induced by Abelson murine leukaemia virus. It is one of the commonly used inflammatory cell models. Cells were cultured in DMEM (Hyclone) medium supplemented with 10% FBS at 37°C in 5% CO~2~. RAW264.7 cells were seeded in six-well plates at a density of 2 × 10^5^ cells/well. Twenty four hours later, the cell medium was replaced with fresh medium. Cells were collected at 0, 2, 4, 8, 12 and 24 h after 1 μg/ml LPS (Sigma--Aldrich, U.S.A.) induction.

*miR-322* mimics transfection {#sec2-2}
-----------------------------

*miR-322* mimics and *miR-322* inhibitors were purchased from GenePharma (China). RAW264.7 cells were seeded into six-well plates for 12 h. The cells were replaced with fresh medium (DMEM + 10% FBS) and transfected with 50 nM *miR-322* mimics and *miR-322* inhibitors using Lipofectaime 2000 (Invitrogen TM, U.S.A.) according to the manufacturer's instructions. After transfection for 24 h, the medium was replaced with fresh medium containing 1 µg/ml LPS. The cells were collected after LPS induction for 8 h.

Quantitative real-time PCR {#sec2-3}
--------------------------

Total RNA was extracted from treated cells with TRIzol (Invitrogen) according to the instructions of the manufacturer. For mRNA analysis, reverse transcription was performed using a first-strand cDNA synthesis kit (Toyobo, Japan). To quantify mature *miR-322* expression, a commercial Bulge-Loop™ miRNA quantitative reverse transcription detection method was used with *miR-322-*specific RT primer ([Table 1](#T1){ref-type="table"}). All gene transcripts were measured by quantitative real-time PCR (qPCR) using a 7500 real-time PCR system (Applied Biosystems) and SYBR Green PCR master mix (Toyobo, Japan). qPCR primers of *miR-322* and the endogenous control gene *U6* were from RiboBio (China), whereas other primers were designed by the Primer Express software and synthesized from Invitrogen ([Table 2](#T2){ref-type="table"}). Fold change was calculated using the 2^−ΔΔ*C*^~^t^~ method of relative quantification. All experiments were conducted in triplicate.

###### 

Nucleic acid sequences for miRNAs

  Gene names                   Sequence (5′ to 3′)
  ---------------------------- ---------------------------------------
  *miR-322* inhibitors         UUCAAAACAUGAAUUGCUGCUG
  Inhibitors NC                CAGUACUUUUGUGUAGUACAA
  *miR-322* mimics             Sense: CAGCAGCAAUUCAUGUUUUGAA
                               Antisense: CAAAACAUGAAUUGCUGCUGUU
  Mimics NC                    Sense: UUCUCCGAACGUGUCACGUTT
                               Antisense: ACGUGACACGUUCGGAGAATT
  *miR-322* stem loop-primer   GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGG
                               ATACGACTTCAAA
  *miR-322*                    Sense: CAGCAGCAATTCATGTTTTGAA
                               Antisense: GTGCAGGGTCCGAGGT
  *U6*                         Sense: CTCGCTTCGGCAGCACA
                               Antisense: AACGCTTCACGAATTTGCGT

###### 

Primers for mRNA

  Primer              Sequence 5′→3′
  ------------------- -----------------------------------------------------
  NF-κB1 UTR-3′-WT    Sense: CC[CTCGAG]{.ul}TTCCAACACCGCATAAACCAAAGC
                      Antisense: ATTT[GCGGCCGC]{.ul}CTGAATCCTTAACTGCTAGGC
  NF-κB1 UTR-3′-MUT   Sense: GTTGTTATTGTGATGGTCCCTCTG
                      Antisense: CAGAGGGACCATCACAATAACAAC
  GAPDH               Sense: GGTGAAGGTCGGTGTGAACG
                      Antisense: CTCGCTCCTGGAAGATGGTG
  IL-1β               Sense: CCTAAAGTATGGGCTGGACTG
                      Antisense: CTCGCTCCTGGAAGATGGTG
  IL-6                Sense: CGGAGAGGAGACTTCACAGAG
                      Antisense: ATTTCCACGATTTCCCAGAG
  TNF-α               Sense: TGAAGGGAATGGGTGTTCAT
                      Antisense: TTGGACCCTGAGCCATAATC
  IL-4                Sense: GGTCTCAACCCCCAGCTAGT
                      Antisense: GCCGATGATCTCTCTCAAGTGAT
  IL-10               Sense: CGGGAAGACAATAACTG
                      Antisense: CATTTCCGATAAGGCTTGG
  Cyclin D1           Sense: TGACACCAATCTCCTCAACG
                      Antisense: CTCACAGACCTCCAGCATCC
  Cyclin E            Sense: CACCTCCAGAACACCACTGA
                      Antisense: AACCTACAACACCCGAGCAG
  P21                 Sense: CAAAGTGTGCCGTTGTCTCT
                      Antisense: TCAAAGTTCCACCGTTCTCG
  P27                 Sense: GCAGATACGAGTGGCAGGA
                      Antisense: ACGAGTCAGGCATTTGGTC

Computational prediction of the miRNA targets {#sec2-4}
---------------------------------------------

To further analyse the functions of *miR*-322, we used three computational approaches, TargetScan (<http://www.targetscan.org/>), PicTar (<http://pictar.mdc-berlin.de/>) and miRBD (<http://mirdb.org/miRDB/>), to predict the targets of *miR-322* in the TLR signalling pathways. Then, the miRNA-binding sites in target genes and the binding free energy were analysed and calculated on the website (<http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/>) \[[@B21]\].

Luciferase reporter assays {#sec2-5}
--------------------------

293T cells were cultured in DMEM medium and seeded in six-well plates at a density of 2 × 10^5^ cells/well. The 3′-UTRs of mouse NF-κB1 (p50) and their corresponding mutated 3′-UTRs were amplified by PCR using the primers shown in [Table 1](#T1){ref-type="table"} and cloned into psiCheck-2 dual-luciferase reporter vector (Promega). Co-transfection was performed with constructed plasmid, miRNA mimics or inhibitors using Lipofectamine 2000. *Renilla* luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions.

Western blotting {#sec2-6}
----------------

Protein concentrations were extracted from cells and measured with the BCA Protein Assay kit (Thermo Scientific), then subjected to SDS/PAGE (10%) gel and transferred to PVDF membranes. The membranes were blocked with 5% BSA. Protein was blotted with different antibodies following the published protocol. All antibodies were obtained from Cell Signaling Technology (U.S.A.). The results were used to visualize the proteins by the ECL reagents (Thermo Scientific) and quantified using Image J 1.44 software (National Institute of Health, Bethesda, Maryland) after densitometric scanning of the films.

Flow cytometry {#sec2-7}
--------------

RAW264.7 cells were transfected with *miR-322* mimics or negative control for 24 h and stimulated with LPS for 24 h. Cells were harvested, washed twice in PBS and fixed in 75% ethanol at 4°C overnight. Staining for DNA content was performed with 50 mg/ml propidium iodide (Sigma, U.S.A.) and 1 mg/ml RNase A for 30 min. Analysis was performed on FACS flow cytometer (BD Co., U.S.A.). The percentage of cells in G~0~/G~1~-, S- and G~2~/M-phases was determined using the Modfit LT Cycle Analysis software.

MTT assay {#sec2-8}
---------

RAW264.7 cells (2 × 10^5^ per well) were seeded in 96-well plates in a final volume of 100 μl. After growing to 70% confluence, 50 nM *miR-322* mimics, inhibitors or negative controls were transfected by lipofectamine 2000. After 24 h, the cells were stimulated with LPS at a dose-gradient of 0, 0.5, 1.0, 1.5 and 2.0 μg/ml. The MTT assay was performed according to the manufacturer's instructions.

Statistical analysis {#sec2-9}
--------------------

Each result represents the mean ± S.E.M. in at least three experiments with similar results. Analyses were conducted using paired two-tailed Student's *t* test with Prism 5.0 (GraphPad Software, San Diego, California) or one-way ANOVA with SPSS 20.0.

Results {#sec3}
=======

LPS stimulates the inflammatory cytokines expression and inhibits the cell-cycle progression in RAW264.7 cells {#sec3-1}
--------------------------------------------------------------------------------------------------------------

LPS-stimulation could activate TLR4/NF-κB signalling pathways and lead to inflammatory response, which could contribute to the cell-cycle procession \[[@B5]\]. The excessive inflammatory response may lead to cell lesions and affect cell proliferation, differentiation and other physiological states. To investigate the effect of LPS on inflammatory response and cell cycle, we detected the mRNA expression levels of inflammatory cytokines, cell-cycle gene in LPS-induced RAW264.7 cells. The results revealed that LPS could promote the mRNA expression level of IL-1β, IL-6 and TNF-α. The expression level of inflammatory cytokines was highest at 4 h or 8h opon with 1 μg/ml LPS,then the expression level decreased gradually ([Figure 1](#F1){ref-type="fig"}). The mRNA expressions of cyclin D and cyclin E were significantly increased, and P21 and P27 were significantly suppressed with time-dependent manner. The results indicated that LPS could mediate inflammatory response and inhibit the procession of cell cycle ([Figure 2](#F2){ref-type="fig"}).

![LPS increases the mRNA expression of inflammatory cytokines in RAW264.7 cells\
RAW264.7 cells were incubated with 1 μg/ml LPS for 0, 2, 4, 8, 12 and 24 h. Total RNA was extracted and the mRNA expression of IL-1β (**A**), IL-6 (**B**) and TNF-α (**C**) were detected with qPCR. Results are representative of three independent experiments performed in triplicate (\*\*\**P*\<0.001).](BSR-2016-0239fig001){#F1}

![LPS inhibits the process of cell cycle of RAW264.7 cells\
RAW264.7 cells were incubated with 1 μg/ml LPS for 0, 2, 4, 8, 12 and 24 h. Total RNA was extracted and the mRNA expressions of cyclin D (**A**), cyclin E (**B**), P21 (**C**) and P27 (**D**) were detected with qPCR. Results are representative of three independent experiments performed in triplicate (\**P*\<0.1, \*\**P*\<0.01 and \*\*\**P*\<0.001).](BSR-2016-0239fig002){#F2}

*miR-322* is down-regulated in LPS-treated RAW264.7 cells {#sec3-2}
---------------------------------------------------------

miR-*322* plays an important role in cell proliferation, cell differentiation, diabetes and male infertility \[[@B18]--[@B20]\]. The role in inflammatory response is not exactly reported. To explore the function of *miR-322* in LPS-induced inflammatory response, the expression level of *miR-322* in LPS-treated RAW 264.7 cells was tested. *miR-322* expression level was dramatically suppressed upon LPS-stimulation and showed a time-dependent manner ([Figure 3](#F3){ref-type="fig"}A). Moreover, the decrease in *miR-322* exhibited a dose-dependent manner with LPS stimulation ([Figure 3](#F3){ref-type="fig"}B). These results suggest that LPS could down-regulate *miR-322* expression. *miR-322* may be involved in the regulation of LPS-mediated inflammatory response.

![Expression of miR-322 is down-regulated in LPS-treated RAW264.7 cells\
(**A**) RAW264.7 cells were incubated with different doses of LPS for 24 h. Total RNA was extracted and *miR-322* levels were detected with qPCR and normalized to endogenous U6. (**B**) RAW264.7 cells were treated with 1 μg/ml LPS at indicated times. *miR-322* levels were detected with qPCR and normalized to endogenous U6. Results are representative of three independent experiments performed in triplicate (\**P*\<0.1, \*\**P*\<0.01 and \*\*\**P*\<0.001; the marked group was compared with the group without LPS treatment).](BSR-2016-0239fig003){#F3}

*miR-322* inhibits LPS-stimulated inflammatory cytokine mRNA expression {#sec3-3}
-----------------------------------------------------------------------

To assess the involvement of *miR-322* on inflammatory cytokine expression, *miR-322* was overexpressed in RAW264.7 cells by transfection of *miR-322* mimics. Cells were treated with 1 μg/ml LPS for 8 h. *miR-322* levels and the mRNA expression levels of inflammatory cytokines including IL-1β, IL-6, TNF-α and anti-inflammatory cytokines including IL-4 and IL-10 were measured by qPCR. We found that the expression of *miR-322* increased after transfection of*miR-322* mimics ([Figure 4](#F4){ref-type="fig"}A). Inflammatory cytokines ( IL-1β, IL-6 and TNF-α) were suppressed after LPS exposure compared with control while overexpression of*miR-322* ([Figure 4](#F4){ref-type="fig"}B--4D) and anti-inflammatory (IL-4 and IL-10 ) were significantly up-regulated ([Figure 4](#F4){ref-type="fig"}E and 4F). These data demonstrated that *miR-322* may negatively regulate LPS-stimulated inflammatory cytokine expression.

![*miR-322* inhibited macrophage inflammatory response\
RAW264.7 cells were transfected with *miR-322* mimics or the negative control for 24 h and then incubated with LPS (1 μg/ml) for 8 h. (**A**) *miR-322* was measured by qPCR and normalized to endogenous U6. (**B**--**D**) mRNA levels of IL-1β, IL-6 and TNF-α were detected with qPCR. (**E** and **F**) mRNA levels of IL-4 and IL-10 were detected with qPCR. Results are representative of three independent experiments performed in triplicate (\*\*\**P*\<0.001).](BSR-2016-0239fig004){#F4}

*miR-322* rescues cell-cycle procession and promotes cell proliferation in RAW264.7 cells {#sec3-4}
-----------------------------------------------------------------------------------------

To investigate the involvement of *miR-322* on cell-cycle procession in RAW264.7 cells, *miR-322* was overexpressed in RAW264.7 cells for 24 h following LPS-stimulation. Then, cell cycle-related genes *cyclin D*, *cyclin E*, *P21* and*P27*mRNA levels were detected by qPCR. The results showed that mRNA expressions of cyclin D and cyclin E were significantly increased, whereas those of P21 and P27 were significantly suppressed ([Figure 5](#F5){ref-type="fig"}). These findings indicated that *miR-322* appeared to promote cell-cycle procession by regulating expression of cell cycle-related genes. To further confirm the impact of *miR-322* on cell-cycle procession, flow cytometry was applied. Cell cycle was arrested in G~0~/G~1~ in RAW264.7 cells following LPS-stimulation. Transfection of *miR-322* increased S and G~2~/M and decreased the population of cells in G~0~/G~1~ ([Figure 6](#F6){ref-type="fig"}). It indicated that LPS-induced cell-cycle repression can be rescued by *miR-322*.

![*miR-322* promotes cell cycle process of RAW264.7 cells\
RAW264.7 cells were transfected with *miR-322* mimics or the negative control for 24 h and then incubated with or without LPS (1 μg/ml) for another 24 h. *Cyclin D*, *cyclin E*, *P21* and *P27* mRNA levels were detected with qPCR. Results are representative of three independent experiments performed in triplicate (\**P*\<0.1 and \*\*\**P*\<0.001).](BSR-2016-0239fig005){#F5}

![*miR-322* rescues cell-cycle procession in RAW264.7 cells\
RAW264.7 cells were transfected with *miR-322* mimics for 24 h, cell-cycle analysis was performed at 24 h after LPS-stimulation. The diagram above displays the percentage changes in G~0~/G~1~ and G~2~/M.](BSR-2016-0239fig006){#F6}

As inflammatory response may lead to cell lesions and affect cell proliferation, we wished to further elucidate the effect of *miR-322* on RAW264.7 cells proliferation. *miR-322* mimics were transfected to RAW264.7 cells and cells were treated with LPS at a dose gradient of 0, 0.5, 1.0, 1.5 and 2.0 μg/ml for 24 h. MTT assay demonstrated that the cell viability was significantly reduced with a dose-dependent manner. *miR-322* could promote RAW264.7 cells proliferation ([Figure 7](#F7){ref-type="fig"}). All these findings suggested that *miR-322* could promote procession of cell cycle and cell proliferation.

![*miR-322* promotes RAW264.7 cells proliferation\
RAW264.7 cells were transfected with *miR-322* mimics or negative control for 24 h and then incubated with LPS at a dose gradient of 0, 0.5, 1.0, 1.5 and 2.0 μg/ml. After 24-h incubation, the MTT assay was performed to determine the proliferation of RAW264.7 cells. Results are representative of three independent experiments performed in triplicate (\**P*\<0.1 and \*\**P*\<0.01).](BSR-2016-0239fig007){#F7}

*miR-322* directly targeted NF-κB1 (p50) through 3′-UTR interaction {#sec3-5}
-------------------------------------------------------------------

To further elucidate the mechanisms of *miR-322* regulating LPS-induced inflammatory response, Targetscan and miRanda were used to predict *miR-322* targets that are related to NF-κB signalling. The analysis results revealed that an *miR-322* seed sequence was predicted in the NF-κB1 3′-UTR. NF-κB1, also named p50, is an important subunit of NF-κB, which affects inflammatory reaction seriously. To test whether *miR-322* can directly bind to NF-κB1 (p50) 3′-UTR, we generated a luciferase construct containing the NF-κB1 (p50) 3′-UTR with the predictive *miR-322*-binding site. In addition, a luciferase construct containing the NF-κB1 (p50) 3′-UTR with a mutation at the putative *miR-322* seed sequence was generated as the control construct ([Figure 8](#F8){ref-type="fig"}A). Two hundred and ninety three T-cells were cotransfected with a psiChecK-2 vector, the luciferase-wild-type NF-κB1 (p50)-3′-UTR (WT-3′-UTR) or the luciferase mutant (MUT-3′-UTR) report vector, as well as *miR-322* mimics or inhibitors. *miR-322* reduced the WT-3′-UTR but not MUT-3′-UTR luciferase levels. These results indicated that *miR-322* could directly target NF-κB1 (p50)-3′-UTR ([Figure 8](#F8){ref-type="fig"}B and 8C). In order to further confirm the regulatory function of *miR-322* to NF-κB1 (p50), we used qPCR and Western blotting to detect mRNA and protein levels of NF-κB1 (p50) in cells transfected with *miR-322* mimics or inhibitors. NF-κB1 (p50) mRNA and protein levels were significantly decreased in cells transfected with *miR-322* mimics, not with *miR-322* inhibitors ([Figure 8](#F8){ref-type="fig"}D--8G). These data suggested that *miR-322* repressed NF-κB1 (p50) expression by directly targeting 3′-UTR of NF-κB1 (p50) mRNA.

![*miR-322* down-regulated NF-κB1 (p50) expression through direct 3′-UTR interaction in RAW264.7 cells\
Schematic diagram of *miR-322*-binding site in NF-κB1 3′-UTR region by bioinformatics analyses. Mutant NF-κB1 (p50) 3′-UTR included several mutations in *miR-322*-binding sites. The blue indicates the seed region and the red indicates the mutant sites (**A**). RAW264.7 cells were cotransfected with psiChecK-NF-κB1 (p50) 3′-UTR (WT--3′-UTR) or psiChecK-NF-κB1 (p50) 3′-UTR mutant (Mut-3′-UTR) along with *miR-322* mimics or mimics control, anti-*miR-322* or anti-*miR-322* control. After 24 h, the luciferase activity was determined and normalized to *Renilla* luciferase activity of three independent experiments (**B** and **C**). RAW264.7 cells were transfected with *miR-322* mimics or mimics control, anti-*miR-322* or anti-*miR-322* control for 24 h, and then NF-κB1 (p50) mRNA levels were measured with qPCR and normalized to GAPDH (**D**). NF-κB1 (p50) and GAPDH were detected by Western blotting at 48 h after RAW264.7 cells were transfected with *miR-322* mimics or mimics control, anti-*miR-322* or anti-*miR-322* control respectively (**E** and **F**). The NF-κB1 (p50) protein expression levels are expressed as a percentage of the *miR-322* group in its control or anti-*miR-322* group in its control (**G** and**H**). Results are representative of three independent experiments performed in triplicate (\**P*\<0.1 and \*\*\**P*\<0.001).](BSR-2016-0239fig008){#F8}

Discussion {#sec4}
==========

Inflammation is the normal self-protection mechanism to eliminate pathogens and resist pathogen invasion \[[@B22],[@B23]\]. The excessive inflammatory response and prolonged inflammation may lead to cell lesions or tissue damage \[[@B24]\]. Here, we found that *miR-322* expression is markedly suppressed in LPS-treated RAW264.7 cells. Subsequent finding suggested that *miR-322* targets 3′-UTR of NF-κB1 (p50) and negatively regulates LPS-modulated inflammatory cytokine expression.

*miR-322*, a member of an evolutionarily conserved *miR-16* family, contributes to promoting osteoblast and muscle cells proliferation, differentiation by directly targeting Tob2 and Cdc25A \[[@B18],[@B25]\]. *miR-322* also plays a crucial role in diabetes, male infertility and other biological processes \[[@B19],[@B20]\]. However, until now, the role of *miR-322* in inflammatory response remains to be further studied. Emerging results indicated that LPS activates NF-κB signalling pathways, causing the release of inflammatory factors such as IL-1β, IL-6 and TNF-α \[[@B26]\]. We found that the expression levels of inflammatory cytokines were significantly increased and cell-cycle procession was seriously inhibited following LPS-stimulation. Meanwhile, the expression level of *miR-322* was down-regulated and was opposite to the inflammatory cytokine mRNA level. Moreover, the anti-inflammatory expression level was up-regulated. The data revealed that *miR-322* may be involved in the regulation of LPS-mediated inflammatory response.

Surveying the predicted targets associated with inflammatory response of *miR-322*, one conserved 7-nt site in the NF-κB1 (p50) 3′-UTR is complementary to the *miR-322* 'seed' region. NF-κB is an important transcription factor that regulates the transcription and expression of multiple genes. It is closely related to the cell activation, cell proliferation, immune response and inflammatory reaction process \[[@B6]\]. The transcription factor p50, the transcript of NF-κB1, is an important subunit of NF-κB. It regulates gene transcription through combination with p65, which is another important subunit of NF-κB. When the signalling pathway is activated, p50/p65 exposes nuclear localization signal and translocates into the nucleus, regulating the transcription of inflammatory cytokine \[[@B2],[@B6]\]. In the present study, the interaction between NF-κB1 (p50) and *miR-322* was analysed by luciferase assay. Luciferase expression level was significantly reduced when cotransfected with *miR-322* and WT-3′-UTR plasmid, whereas no significant modulation was observed with [Mut]{.smallcaps}-3′-UTR. Furthermore, we found that overexpression of *miR-322* reduced expression of NF-κB1 (p50) mRNA and protein. Meanwhile, the expression level of inflammatory cytokines was inhibited by *miR-322* following LPS-stimulation. LPS/TLR4/NF-κB signalling pathway plays a crucial role in cell inflammatory effect. *miR-322* can target 3′-UTR of NF-κB1 (p50), which indicated that TLR4 receptor and its signalling pathway may be involved in the process. Taken together, these results indicated that *miR-322* negatively regulated LPS-mediated inflammatory response by directly targeting NF-κB1 (p50).

NF-κB signalling cascade involved in macrophage inflammatory response. Macrophages initiate the innate immune response and deal with antigen to T-cells regulating the adaptive immunity \[[@B27]\]. Macrophages protect the body from infection and produce various inflammatory cytokines. Nevertheless, overproduced cytokines may cause cell damage and result in pathological condition. Previous studies reported that many miRNAs are useful modulators in maintaining cell homoeostasis by regulating cell-cycle proteins \[[@B28],[@B29]\]. In the present study, the function of*miR-322* in cell proliferation and cell cycle was investigated in macrophages. We found that RAW264.7 cell cycle was arrested in G~0~/G~1~ phase and cell proliferation was significantly inhibited following LPS stimulation. We also found a decrease in *miR-322* expression level in LPS-treated RAW264.7 cells. It indicated that *miR-322* is involved in RAW264.7 cell proliferation. In the subsequent research, overexpression of *miR-322* increased cell cycle arrest at G~2~/M-phase and the number of cells in G~0~/G~1~ was significantly decreased. Besides, LPS-induced cell proliferation repression was rescued by *miR-322*. These data suggested that *miR-322* could promote cell proliferation and arrest cell cycle following LPS-stimulation.

In summary, we had proved for the first time that NF-κB1 (p50) was a novel target of *miR-322*. Our data provided evidence that LPS-induced down-regulation of *miR-322* and its subsequent effects on NF-κB-mediated transcriptional activity are responsible for fine-tuning inflammatory responses in RAW264.7 cells. Besides, *miR-322* plays a significant role in RAW264.7 cell proliferation. However, the specific mechanisms of *miR-322* regulation of cell-cycle procession and cell proliferation remain to be further elucidated. Overall, *miR-322* may provide a new perspective for the treatment of inflammatory diseases.
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